Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents

This publication has 34 references indexed in Scilit:

• Report of the Twenty-Fourth Meeting of the Standing Committee: (24-26 June 2002)
  Refugee Survey Quarterly, 2002
• Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration
  Vaccine, 2001
• The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent Mechanism
  Infection and Immunity, 2001
• A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adults
  Vaccine, 2000
• The Effect of Adsorption with Aluminium Hydroxide on the Reactogenicity of Pertussis Vaccines
  Biologicals, 1999
• Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with diphtheria–tetanus–whole cell pertussis vaccine before 2 years of age
  Vaccine, 1999
• Adjuvants—a classification and review of their modes of action
  Published by Elsevier ,1998
• Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants
  The Journal of Pediatrics, 1996
• Acellular Pertussis Vaccines
  Drug Safety, 1996
• Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children
  European Journal of Pediatrics, 1993